DE60102590D1 - Darreichungsformen zur behandlung von oralen mykosen - Google Patents

Darreichungsformen zur behandlung von oralen mykosen

Info

Publication number
DE60102590D1
DE60102590D1 DE60102590T DE60102590T DE60102590D1 DE 60102590 D1 DE60102590 D1 DE 60102590D1 DE 60102590 T DE60102590 T DE 60102590T DE 60102590 T DE60102590 T DE 60102590T DE 60102590 D1 DE60102590 D1 DE 60102590D1
Authority
DE
Germany
Prior art keywords
pharmaceutical forms
treating oral
oral mycosis
mycosis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60102590T
Other languages
English (en)
Other versions
DE60102590T2 (de
Inventor
Joerg Rosenberg
Gunther Berndl
Joerg Neumann
Joerg Breitenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Priority to DE60102590T priority Critical patent/DE60102590T2/de
Publication of DE60102590D1 publication Critical patent/DE60102590D1/de
Application granted granted Critical
Publication of DE60102590T2 publication Critical patent/DE60102590T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DE60102590T 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen Expired - Lifetime DE60102590T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE60102590T DE60102590T2 (de) 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10038571A DE10038571A1 (de) 2000-08-03 2000-08-03 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
DE60102590T DE60102590T2 (de) 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen
PCT/EP2001/008978 WO2002011694A2 (en) 2000-08-03 2001-08-02 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses

Publications (2)

Publication Number Publication Date
DE60102590D1 true DE60102590D1 (de) 2004-05-06
DE60102590T2 DE60102590T2 (de) 2005-04-21

Family

ID=7651652

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10038571A Withdrawn DE10038571A1 (de) 2000-08-03 2000-08-03 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
DE60102590T Expired - Lifetime DE60102590T2 (de) 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10038571A Withdrawn DE10038571A1 (de) 2000-08-03 2000-08-03 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen

Country Status (13)

Country Link
US (1) US20040029892A1 (de)
EP (1) EP1305010B1 (de)
JP (1) JP2004505905A (de)
CN (1) CN1274297C (de)
AT (1) ATE262893T1 (de)
AU (1) AU2001295448A1 (de)
BR (1) BR0112847A (de)
CA (1) CA2417709C (de)
DE (2) DE10038571A1 (de)
ES (1) ES2218456T3 (de)
RU (1) RU2003105812A (de)
WO (1) WO2002011694A2 (de)
ZA (1) ZA200301672B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175205B1 (de) * 1999-11-12 2006-06-14 Abbott Laboratories Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
CN1309425C (zh) * 2001-11-05 2007-04-11 奥拉黑尔斯公司 用贴片治疗口腔溃疡以加速痊愈和缓解疼痛的方法
JP2005538973A (ja) * 2002-07-04 2005-12-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 異なる2種類のポリマーマトリックスを含んで成る固体分散体
DE10332160A1 (de) 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
BRPI0418330A (pt) 2003-12-31 2007-05-02 Pfizer Prod Inc composições sólidas de drogas de solubilidade baixa e poloxámeros
CN1294912C (zh) * 2004-03-01 2007-01-17 上海医药工业研究院 伊曲康唑盐酸盐组合物及其冻干粉针
JP2006096728A (ja) * 2004-09-30 2006-04-13 Kobayashi Pharmaceut Co Ltd 口腔内定着型固形製剤
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
EP2037895A4 (de) * 2006-05-23 2009-12-02 Orahealth Corp Xylitol-pastillen und anwendungsverfahren
CN101108172B (zh) * 2006-07-17 2010-10-06 天津药物研究院 一种口腔粘贴片及其制备方法
GB0703998D0 (en) 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
ES2511145T3 (es) * 2010-10-14 2014-10-22 Abbott Gmbh & Co. Kg Formulación de dispersión sólida de curcuminoides
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
US5431915A (en) * 1993-12-20 1995-07-11 Harvey; Bryce M. Frozen oral medication delivery system and method
JPH0920680A (ja) * 1995-01-24 1997-01-21 Hideyo Yamaguchi 抗真菌剤
DE19539359A1 (de) * 1995-10-23 1997-04-24 Knoll Ag Formbandkalander
HU227745B1 (en) * 1996-05-20 2012-02-28 Janssen Pharmaceutica Nv Antifungal compositions containing itraconazole
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen

Also Published As

Publication number Publication date
ATE262893T1 (de) 2004-04-15
US20040029892A1 (en) 2004-02-12
CA2417709A1 (en) 2002-02-14
CA2417709C (en) 2010-05-11
EP1305010B1 (de) 2004-03-31
CN1274297C (zh) 2006-09-13
DE60102590T2 (de) 2005-04-21
BR0112847A (pt) 2003-06-24
WO2002011694A2 (en) 2002-02-14
JP2004505905A (ja) 2004-02-26
ES2218456T3 (es) 2004-11-16
ZA200301672B (en) 2004-03-01
CN1444473A (zh) 2003-09-24
EP1305010A2 (de) 2003-05-02
DE10038571A1 (de) 2002-02-14
AU2001295448A1 (en) 2002-02-18
RU2003105812A (ru) 2004-09-27
WO2002011694A3 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
DK1169024T3 (da) Prægelatineret stivelse i en formulering med kontrolleret frigivelse
GEP20074047B (en) Pramipexole once-daily dosage form
ATE320799T1 (de) Retardierte, orale, pharmazeutische darreichnungsformen mit tramadol
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NO20030627L (no) Hydrogel-drevet medikament doseringsform
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
AR032293A1 (es) Estuche farmaceutico
ATE541562T1 (de) Ibuprofen-suspension
BG108516A (en) Pharmaceutical formulation
ES2195638T3 (es) Preparaciones de combinaciones farmaceuticas en forma solida de dosificacion que contienen cardevilol e hidroclorotiazida.
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
DE60019334D1 (de) Antivirale arznei
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
IL154731A0 (en) Ion-strength independent sustained release pharmaceutical formulation
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
SE0001916D0 (sv) Novel formulation
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
MY141008A (en) Oral formulations of deoxypeganine and their uses
DK1499278T3 (da) Farmaceutisk doseringsform, som udviser umiddelbar frigivelse, og som omfatter polymorf tibolon
UY27345A1 (es) Formulación farmacéutica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition